ID: ALA4785541

Max Phase: Preclinical

Molecular Formula: C18H28O3

Molecular Weight: 292.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCc1ccc(C(=O)O)c(O)c1

Standard InChI:  InChI=1S/C18H28O3/c1-2-3-4-5-6-7-8-9-10-11-15-12-13-16(18(20)21)17(19)14-15/h12-14,19H,2-11H2,1H3,(H,20,21)

Standard InChI Key:  ZKBFYCMMQHSQHB-UHFFFAOYSA-N

Associated Targets(Human)

Small ubiquitin-related modifier 1 633 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.42Molecular Weight (Monoisotopic): 292.2038AlogP: 5.16#Rotatable Bonds: 11
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.97CX Basic pKa: CX LogP: 6.94CX LogD: 3.46
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.55Np Likeness Score: 0.42

References

1. Brackett CM,García-Casas A,Castillo-Lluva S,Blagg BSJ.  (2020)  Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.,  11  (11): [PMID:33214832] [10.1021/acsmedchemlett.0c00353]

Source